Yifan Liu

Yifan Liu

Auto-generated profile, based on publicly available information

Yifan Liu

Lab of Environmental Health and Ecological Engineering, College of Marine Life Science, Ocean University of China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Bioactive Materials
Verified
Journal Article
Open access
HTHuanfeng Tang
Huanfeng Tang
YLYifan Liu
Yifan Liu
BLBing Li
Bing Li
BSBo Shang
Bo Shang
JYJiacheng Yang
Jiacheng Yang
JLJianfeng Liu
Jianfeng Liu
The major challenge in the field of antibacterial agents is to overcome the low-permeability of bacteria cell membranes that protects the cells against diverse drugs. In this work, water-soluble polyaniline (PANI)-poly (p-styrenesulfonic acid) (PSS) (PANI:PSS) is found to spontaneously penetrate bacteria cellular membranes in a non-disruptive way, leaving no evidence of membrane poration/disturbance or cell death, thus avoiding side effects caused by cationic ammonia groups in traditional ammonia-containing antibacterial agents. For aqueous synthesis, which is important for biocompatibility, the polymer is synthesized via an enzyme-mimetic route relying on the catalysis of a nanozyme. Owing to its fluorescent properties, the localization of as-prepared PANI:PSS is determined by the confocal microscope, and the results confirm its rapid entry into bacteria. Under 808 nm near-infrared (NIR) irradiation, the internalized PANI:PSS generates local hyperthermia and destroys bacteria highly efficiently from inside the cells due to its excellent photothermal effects. Staphylococcus aureus (S. aureus), M ethicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli (E. coli) could be effectively eliminated as well as the corresponding bacterial biofilms. Results of in vivo antibacterial experiments demonstrate excellent antibacterial activities of the water-soluble PANI:PSS without side effects. Therefore, the prepared water-soluble polymer in this study has great potential in the treatment of various bacterial infections.

5 June 2024 in ACS Omega
Verified
Journal Article
Open access
YLYifan Liu
Yifan Liu
PCPengfei Cui
Pengfei Cui
RTRong Tan
Rong Tan
SRShaoguo Ru
Shaoguo Ru
Antimicrobial peptides (AMPs) are a type of biomaterial used against multidrug resistant (MDR) bacteria. This study reports the design of a peptide family rich in tryptophan and lysine obtained by optimizing a natural AMP using single factor modification and pheromone hybridization to expedite the penetration and improve the antimicrobial activity of AMPs. S-4, L-4, and P-4 showed α-helical structures, exhibited extremely fast membrane penetration rates in vitro, and could kill MDR bacteria efficiently within 30 min. Intracellular fluorescence localization suggested rapid membrane-penetrating of AMPs within 1 min, making it more difficult for bacteria to develop resistance. Furthermore, they could effectively inhibit and destroy bacterial biofilms with dual antimicrobial and antibiofilm activity. In the treatment of skin infections caused by MDR-Acinetobacter baumannii in vivo , AMPs could effectively alleviate inflammation without toxic side effects. Additionally, the triple antimicrobial damage of AMPs was described in detail. AMPs rapidly penetrate the cell membrane, inducing cell membrane damage, triggering oxidative damage with a storm of reactive oxygen species and leading to bacterial death through leakage of cellular contents by complexing with DNA. The multiple damage is an important means by which AMPs can prevent bacterial resistance adequately.

4 February 2026 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
YLYifan Liu
Yifan Liu
PCPengfei Cui
Pengfei Cui
JSJingyi Sun
Jingyi Sun
SRShaoguo Ru
Shaoguo Ru
The escalating threat posed by multidrug-resistant (MDR) Gram-negative “superbugs” has intensified. Short antimicrobial peptides (SAMPs) have emerged as promising therapeutics with sustained potency and cost-effectiveness against drug-resistant infections. Here, we report a family of 15-residue SAMPs derived through modifying related amino acids of Kassporin-KS1 (FA), utilizing database-filtering technology to identify the most probable structural parameters related to Gram-negative bacteria. Most SAMPs exhibit sub-μM antimicrobial activity with reliable stability and low toxicity. Notably, KR and RK demonstrate significant efficacy in combating biofilms and sepsis infections in vivo . Furthermore, the acquisition of resistance by strains to SAMPs was not observed, primarily due to the multimodal antimicrobial mechanisms of SAMPs. We revealed that the multimodal mechanisms of SAMPs encompass unregulated membrane destabilization, induction of apoptotic-like death pathway, and interference with normal physiological processes. Overall, the rational design strategies proposed herein can be implemented to develop potent antimicrobial agents targeting MDR bacteria.